Metraipolis › archive › dc_4ec3ad4447c8
Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection — Europe PMC PMID:42164511
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42164511
- DOI
- 10.3389/fimmu.2026.1787877
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T18:39:25.200Z
- SHA-256 of the archived text
645a8c5654403cf0305292928d9a61ccf54e68b8248529aede11054d3479d8fd- Stable URL of this page
https://metraipolis.com/documento/dc_4ec3ad4447c8
How to cite
Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection — Europe PMC PMID:42164511 — Europe PMC (en), https://europepmc.org/article/MED/42164511 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ec3ad4447c8 (Metraipolis archive dc_4ec3ad4447c8, sha256 645a8c5654403cf0305292928d9a61ccf54e68b8248529aede11054d3479d8fd)
BibTeX
@misc{dc4ec3ad4447c8,
title = {Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection — Europe PMC PMID:42164511},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42164511},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ec3ad4447c8; sha256 645a8c5654403cf0305292928d9a61ccf54e68b8248529aede11054d3479d8fd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42164511. Agents can read the archived copy with the MCP tool read_document.